Febseltiq
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Febseltiq, covering 2023-01-30 to 2023-01-30. Get the full timeline:
Most recent: EMA Application withdrawn: Febseltiq (Infigratinib monophosphate) — Helsinn Birex Pharmaceuticals Ltd